Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
Taiki HashimotoDaisuke TakayanagiJunpei YonemaruTomoaki NakaKengo NagashimaYasushi YatabeDai ShidaRyuji HamamotoSam O KleemanSimon J LeedhamTimothy S MaughanAtsuo TakashimaKouya ShiraishiShigeki SekinePublished in: British journal of cancer (2022)
RSPO fusion-positive CRCs constitute a rare subgroup of CRCs with several characteristic clinicopathological and genetic features.